Industry landscapes
Industry report

Funding and advertised pay are reported in USD; filed accounts retain their stated source currency and basis.

Exchange-rate basis

Indicative conversions use ECB reference rates dated 2026-09-14, applied consistently across all periods. They are not historical exchange rates. Indian rupees may use crore (1 crore = 10 million); other currencies use K, M and B. CSV downloads, source documents and quoted news headlines retain their original currencies.

THE THE UNITED KINGDOM EDITION 2026

the United Kingdom’s
wearables industry,
in focus.

The companies, capital and talent shaping wearables in the United Kingdom. Find the leaders. Understand the segments. See where the activity is.

Snapshot: Funding in USD
Illustrated cover for Wearables Industry Landscape of the United Kingdom
GB
COMPANIES · CAPITAL · TALENT

An industry ecosystem,
measured in context.

Wearables illustration
MEET THE COMPANIES

Explore the United Kingdom’s wearables leaders

24 featured companies from the funding, hiring, revenue and team-size leaderboards.

Expand panel +
Wearables company highlights in the United Kingdom, snapshot 4 September 2026
Company
Elvieelvie.com$157.63M102
PD Neurotechnologypdneurotechnology.com$93.63M32$3.37MFYFY2023 filing
Current healthcurrenthealth.com$79.12M1
Playermakerplayermaker.com$50M1
Savasava.health$38.48M34
Health Hero Networkhealthhero.com$34M1 roles10
Elekseneleksen.com$25.75M19
Shot Scopeshotscope.com$25.23M18
Circadiacircadia.health3 roles8
Sweat Economysweateconomy.com3 roles22
EarSwitchearswitch.co.uk2 roles1
Fiitfiit.tv2 roles43Financial figure available in RadarView in Radar
Activinsightsactivinsights.com1 roles16
TestCardtestcard.com1 roles39
ZELPzelp.co1 roles6
Catapultcatapult.com3
Cumulus Neurocumulusneuro.com41
Mindspiremindspire.co.uk
MyHealthCheckedmyhealthchecked.com21
PetScannerpetscanner.com
RunningAHEADrunningahead.com
SleepCognisleepcogni.com3
SleepImagesleepimage.com
Stancestancefitness.co3
24 featured companies

Locked revenue figures are available in Radar; the eight company financial previews stay the same throughout this page. A dash means the figure is outside these featured lists. Revenue years vary by company; the figures are not a like-for-like revenue comparison. Compare annual accounts ↗

Company discovery

Recorded evidence only

Explore the live startup set in Radar

No company example met every recorded classification, independence and public-profile gate in this snapshot. The live directory may have newer qualifying companies.

Explore classified startups in Radar ↗
THE KEY SIGNALS

Wearables industry KPIs in the United Kingdom

A few useful ratios bring the size of this ecosystem into perspective.

4 September 2026
Hiring participation2.9%

9 of 310 tracked companies have open roles.

Funding participation30.3%

94 of 310 tracked companies have a recorded round.

Top 3 funding share35.7%

Share of disclosed capital received by the three largest recorded recipients.

Median disclosed round$1M

Midpoint of 206 rounds with a disclosed amount.

Scale is concentrated. Opportunity is broader. The three largest funding recipients hold 35.7% of disclosed capital, while 69.7% of tracked companies have no recorded funding round.

Explore the segments →
CAPITAL & COMPANY FORMATION

How the United Kingdom wearables has grown

Recorded company formation and disclosed funding across the complete annual series shown.

Expand panel +
2016 — 2025

Disclosed funding by year

Sum of recorded funding rounds · USD

the United Kingdom wearables
$0$58.29M$116.58M$174.87M$233.16M2016: $99.61M20162017: $53.44M20172018: $30.23M20182019: $103.11M20192020: $33.2M20202021: $204.52M20212022: $139.15M20222023: $55.83M20232024: $60.33M20242025: $45.28M2025
View the numbers
Annual wearables funding and company formation in the United Kingdom
YearFunding (USD)FoundedRaising
2016$99.61M3213
2017$53.44M2419
2018$30.23M2214
2019$103.11M2719
2020$33.2M3819
2021$204.52M2020
2022$139.15M1019
2023$55.83M1013
2024$60.33M315
2025$45.28M18
WHERE CAPITAL SITS

Funding concentration

Share of all disclosed company funding.

  • Elvie17.0%
  • PD Neurotechnology10.1%
  • Current health8.6%
  • Other companies64.3%

Funding by stage

237 recorded rounds since 2016

NUMBER OF ROUNDS
Seed & Angel127 53.6%
Series A–B58 24.5%
Series C+ / PE5 2.1%
Grants, debt & other47 19.8%

Recent recorded rounds

Latest recorded rounds · USD
0 rounds

Swipe or scroll horizontally to browse.

Largest and notable recorded rounds

Each card is one recorded round
10 cards

Swipe or scroll horizontally to browse.

Series B04/2019
Elvieelvie.com$42.09M

Backed by Octopus Ventures and Impact Ventures UK and others.

Series A07/2025
Savasava.health$19.09M

Backed by Balderton Capital and Pentland Ventures and others.

THE BUSINESS BEHIND THE ACTIVITY

Revenue, profitability & financial strength

Annual accounts for reporting companies linked to this landscape, on like-for-like currency and reporting bases.

Expand panel +
GBP · millions · consolidated

Display conversions use the dated reference rates above. Where a verified rate is unavailable, figures retain their source currency. Each reporting cohort keeps its currency and accounting basis separate.

FY2025 · company accounts; aggregate reporting threshold not met · 1 reporting entities from 104 eligible matches.

Revenue in covered accounts

Sum of reporting-entity revenue; not the United Kingdom market sales.

Net profit / loss

Combined result for the same cohort.

Aggregate net margin

Combined net income ÷ combined revenue.

Median company revenue

The middle covered reporting entity.

Profitable entities

None of 1 covered entities.

Top-five concentration

Share of covered revenue from the five largest entities.

Annual account trend

Reported cohort totals by year; coverage is stated for every period.

Bar height shows revenue. Changes in coverage can affect totals.

Profitability has two perspectives

FY2025 · 1 reporting entities

Open the company accounts

Up to eight fixed company previews show financial amounts. Search and sort the wider company list, then continue in Radar.

1 reporting entities
Continue your financial research in Radar

Explore full company accounts and filings.

View financials in Radar ↗
THE UNITED KINGDOM · INDUSTRY COHORTS

How does wearables compare?

Each pair uses the same year, currency and reporting basis. Cohort overlap is disclosed.

IndustryCovered / eligibleRevenue totalMedian revenueNet profit / lossAggregate marginProfitable shareOverlap

Available-account cohorts are not estimates of whole industries. Overlapping entities can occur in more than one cohort; do not add cohort totals.

Coverage, calculations & financial sources

Filed annual accounts for exact designated national identifiers. Every aggregate and peer pair uses one fiscal year, source currency and reporting basis; periods, coverage and overlap are explicit; 2026 partials are excluded.

The same up to eight reporting entities remain open across years, filters and sorts. Other company figures are available in Radar.

Source currencies and accounting bases stay separate. Missing accounts are excluded rather than treated as zero. Exact reporting periods appear on company previews. Annual totals can change with coverage and do not measure growth of a fixed company cohort.

DIGITAL FOOTPRINT

Web traffic, app reach and release cadence

How the the United Kingdom companies on this page show up online: the sites people visit, the apps they install, and how often those apps ship.

Most-installed apps

69 of these companies (22.3%) publish at least one Android app — 99 apps in all, carrying 158.1M installs between them.

AppInstallsRatingStore category
Sweatcoin・Walking Step CounterSweatcoin154.9M4.3Health & Fitness
Fiit: Home Workouts & FitnessFiit410K4.3Health & Fitness
SleepImageSleepImage322.1K2.6Health & Fitness
PetScanner Find.Scan.Reunite.PetScanner307.7K1.7Lifestyle
Map My Tracks - bike run walkMap My Tracks256K3.8Health & Fitness
Pump with ElvieElvie239K4Health & Fitness
Mariner Sailing GPS & LogbookWatch & Navy220.1K3.9Maps & Navigation
Easy Kegel - Pelvic FloorEasy Kegel205.4K4.7Health & Fitness
Velocity GPS Speed DashWatch & Navy148.1K3.8Maps & Navigation
Shot ScopeShot Scope131.9K4.5Sports

Installs are lifetime totals to date at the June 2026 store reading — a measure of reach, not of people using an app today.

App reach by segment

The busiest app inside each of this page’s own segments, with the quarterly release trend behind it (2023Q4–2026Q2).

SegmentAppsInstallsLeading appRelease trend
Fitness & Wellness Tech53156.8MSweatcoin・Walking Step Counter 154.9M
Wearable Technology721.9MSleepImage 322.1K
Disease Self Management29715.7KPump with Elvie 239K
Security & Surveillance Technology12476.6KMariner Sailing GPS & Logbook 220.1K
Geographic Information Systems6443.2KVelocity GPS Speed Dash 148.1K
Road Transport Tech5441.1KMulti-Device Energy Monitor AI 71.1K
Pet Tech3385.3KPetScanner Find.Scan.Reunite. 307.7K
Consumer Electronics E-Commerce9374.9KElvie Trainer 120K

A company can carry several segment tags, so these rows overlap and should not be added together. Trend lines are zero-based and share one quarter grid, so a flat line is a quiet segment, not a missing one.

Release cadence by quarter

New apps published, beside apps whose most recent update landed in that quarter — the second bar is how much of the shelf is still being maintained.

2023Q1: 32023Q1: 02023Q12023Q2: 12023Q2: 22023Q22023Q3: 12023Q3: 02023Q32023Q4: 22023Q4: 12023Q42024Q1: 22024Q1: 12024Q12024Q2: 32024Q2: 32024Q22024Q3: 12024Q3: 42024Q32025Q1: 22025Q1: 92025Q12025Q2: 32025Q2: 32025Q22025Q3: 32025Q3: 82025Q32025Q4: 12025Q4: 62025Q42026Q1: 32026Q1: 162026Q1

Darker bars are new releases, lighter bars apps updated. 88 of 99 apps carry a release date. The series ends at 2026Q1, the last quarter that closed before the June 2026 reading.

INSIDE THE INDUSTRY

The the United Kingdom wearables market map

Explore the segments behind the headline numbers.

Expand panel +

Where companies are building

Rank segments by scale, hiring or disclosed funding.

Healthtech245
Consumer digital240
Consumer internet of things152
Iot in healthcare149
Medical devices104
Life sciences102
Enterprise tech98
Fitness and diet apps82
Chronic disease management81
Non-invasive health monitoring devices77
Iot in retail70
Hospital at home58

Companies can sit in several segments. Counts and funding overlap.

SEGMENT TO EXPLORE

Healthtech

The largest measured segment in this report snapshot.

245companies
3.3%have hiring activity

8 companies hiring · $891.6M disclosed funding

Explore in Radar

How companies make money

Common revenue models; a company can use more than one.

Subscription222
E-commerce - product81
Physical commerce71
Commission on transaction8
Fee-for-service8
E-commerce - service6
Advertising5
Sponsorship1
THE COMPANIES IN MOTION

Who is listing, hiring leaders, launching and winning work

Recorded corporate activity linked to companies in this landscape.

Expand panel +
Recent corporate headlines 10 dated reports
Funding roundstidalsense.com ↗

We've also invested in Tidalsense, which has developed an AI-driven device for assessing chronic obstructive pulmonary disease.

Mergers & acquisitionsreactec.com ↗

Ideagen, a compliance and risk management software company based in Ruddington, Nottingham, UK, has acquired Reactec, an Edinburgh-based provider of wearable technology with data analytics.

Funding roundscumulusneuro.com ↗

Belfast medtech Cumulus Neuroscience has raised £3.25m in a round led by fund manager Whiterock Finance.

Mergers & acquisitionscurrenthealth.com ↗

In 2021 press release announcing the acquisition, Best Buy Health President Deborah Di Sanzo noted that combining Current Health's platform with Best Buy's consumer health products and services would help "create a holistic care ecosystem."

Funding roundsmindspire.co.uk ↗

A NeuroTech startup dedicated to helping people regulate stress and unlock peak performance has raised £850,000 in pre-seed funding.

Mergers & acquisitionselvie.com ↗

Willow Innovations has announced its acquisition of UK-based femtech innovator Elvie.

Funding roundsstrolll.co ↗

Stafford-based Stroll, a digital therapeutic software company that uses augmented reality (AR) glasses to provide neurorehabilitation to patients living with neurological disorders has raised a €12.2 million Series A funding round.

Funding roundshealthhero.com ↗

Health Hero Network (Redwood City, California) said it has secured $16 million in an oversubscribed Series B financing to underwrite ongoing new product development and marketing for its Health Buddy System.

Funding roundssleepcogni.com ↗

Sheffield‑based insomnia medtech firm SleepCogni has raised £300,000, bringing its total funding to £3.9m.

Earningscatapult.com ↗

Catapult Sports Ltd (ASX: CAT), the Melbourne-based sports performance technology company, has released a preliminary trading update for its financial year ending March 31, 2026, reporting annualised contract value in the range of US$133 to US$134 million, representing year-on-year growth of 27 to 28 percent on a constant currency basis.

Full recorded event mix

Top 9 categories among 33 recorded events in the 24-month window.

Funding rounds
11
Capital infusions
6
Mergers & acquisitions
5
Earnings
3
Leadership moves
2
Company announcements
2
New products
2
Contracts
1
Asset acquisitions
1
2 activity cards

Swipe or scroll horizontally to browse.

Product launches

Products, platforms and features in the recorded window

Catapult ↗
Slingshot Implementation Packages

Product

Mergers and acquisitions

Company-linked deal reports; status is preserved as recorded.

Acquirer → targetStatusDateValue / context
ideagenReactec ↗Announced2025-08-18Not stated in snapshot
best buyCurrent health ↗Completed2025-06-26$400.0M
Christopher McGheeCurrent health ↗Announced2025-06-26Not stated in snapshot
willowElvie ↗Announced2025-04-02Not stated in snapshot
Eli Lilly and CompanyAparito ↗Completed2024-07-15Not stated in snapshot
fitbitVector Watch ↗Completed2024-05-29Not stated in snapshot

A discussion or rumour is not a completed transaction. An unstated value is not zero.

PEOPLE & OPPORTUNITY

The talent market

5 postings in the preceding 12 months. The full 20-posting snapshot covers 2 employers.

Expand panel +

Most advertised job titles

Specialty Doctor1
Band 7 Echocardiographer1
0 internship postings

10 tracked postings mention remote work.

Skills employers mention

Top skills across 20 tracked postings in the available jobs snapshot.

Lan
3
Systems Engineering
3
Pro2 Replication
3
Wan
3
Devops
3
Openedge
3
Data Platforms
2
Findability
2
Semaphore
2
Mutual Success Planning
2
THE PEOPLE BUILDING THE FIELD

Founders and leaders

205 founders and chief executives across 160 companies.

Expand panel +
12 profiles

Swipe or scroll horizontally to browse.

Education networks

34 profiles with education records.

University of Cambridge
7
Imperial College London
5
University of Oxford
4
University College London
3
London Business School (LBS)
3
INSEAD
2
University of Edinburgh
2
London School of Economics and Political Science
1

Prior employers

6 profiles with prior-work records.

Boston Consulting Group
2
Amazon
1
Intel
1
Facebook
1
Google
1
Apple
1

Profiles cover recorded founders and leaders; contact details remain in Radar.

NEWS INTELLIGENCE

How this industry appears in the news

672,507 articles in the measured 12-month window.

Expand panel +
672,507articles in the measured year
113,294articles in 2026Q1
37.1%positive tone in the latest complete year

News volume trends

Wearables coverage across United Kingdom · articles per complete quarter

0103,422206,844310,265413,6872021Q2: 78,6082021Q22021Q3: 83,1972021Q4: 75,4052022Q1: 87,0592022Q2: 81,8682022Q22022Q3: 81,8092022Q4: 93,4922023Q1: 94,6492023Q2: 100,2822023Q22023Q3: 105,2672023Q4: 91,6302024Q1: 103,2072024Q2: 109,1792024Q22024Q3: 117,9532024Q4: 122,6722025Q1: 165,4932025Q2: 124,2812025Q22025Q3: 359,7282025Q4: 86,0062026Q1: 113,2942026Q1
View quarterly article counts
QuarterArticles
2021Q278,608
2021Q383,197
2021Q475,405
2022Q187,059
2022Q281,868
2022Q381,809
2022Q493,492
2023Q194,649
2023Q2100,282
2023Q3105,267
2023Q491,630
2024Q1103,207
2024Q2109,179
2024Q3117,953
2024Q4122,672
2025Q1165,493
2025Q2124,281
2025Q3359,728
2025Q486,006
2026Q1113,294

Article volume measures coverage, not market sales.

Tone of coverage over time

2021
138,369 positive · 33,837 neutral · 80,228 negative
2022
184,028 positive · 52,696 neutral · 107,077 negative
2023
221,826 positive · 65,346 neutral · 104,271 negative
2024
241,447 positive · 99,918 neutral · 111,001 negative
2025
272,767 positive · 156,834 neutral · 305,246 negative

Leading coverage topics

Wearables coverage across United Kingdom · ranked by full-period article count.

Geopolitical Disputes And Contested Areas300,176 articles in the full recorded period
108,090 recent · 81,378 prior
International And Transnational Geographic Entities300,176 articles in the full recorded period
108,092 recent · 81,381 prior
Administrative And Political Subdivisions300,134 articles in the full recorded period
108,069 recent · 81,373 prior
International Political Relations43,154 articles in the full recorded period
12,771 recent · 8,846 prior
Cryptocurrency Impact On Forex Markets29,875 articles in the full recorded period
8,131 recent · 5,405 prior
Security And Defense Policies28,074 articles in the full recorded period
8,919 recent · 6,044 prior
International Relations And Diplomacy20,045 articles in the full recorded period
5,536 recent · 4,513 prior
Trade Policies And Agreements16,248 articles in the full recorded period
7,114 recent · 4,500 prior
International Sports Competitions15,455 articles in the full recorded period
3,432 recent · 3,934 prior
Strategic Partnerships And Collaborations14,206 articles in the full recorded period
3,809 recent · 3,006 prior

Recent and prior counts use the source comparison windows.

Topics gaining and losing attention

Wearables coverage across United Kingdom

KeywordRecentPriorChange
countries4,1921,862125%
tariff negotiations4,1502,43670%
stock performance2,4031,57852%
free trade deals2,2271,063110%
startup news2,040494313%
trade dispute mechanisms1,928804140%
bilateral trade1,830732150%
foreign policy analysis1,42493552%
multilateral diplomacy1,41280176%
national security strategy1,252538133%
free casino games711,153-94%
social casino691,149-94%
simulated gambling apps691,147-94%
sweepstakes casino681,147-94%
fun play casinos691,144-94%

Event and signal lenses

Wearables coverage across United Kingdom

All complete annual cohorts shown
Rising

Regulatory Risk

838,808 classified articles

territories, disputed islands, countries

26.8% critical · 18.1% positive
Rising

Funding Momentum

107,044 classified articles

angel investors, inflation reports fx, currency intervention policies

40.1% critical · 50.2% positive
Rising

Growth

190,729 classified articles

gdp growth forex, inflation reports fx, stock performance

30.8% critical · 50.8% positive

Wearables coverage across United Kingdom. Topic labels describe recorded classifications and can include broad context.

RESEARCH SIGNALS

What Wearables research is working on

12,507 papers in the recorded worldwide scope.

Expand panel +
12,507papers
12,507worldwide comparison pool
India-affiliated papers

Research orientation

Promising
4,207
Descriptive
3,081
Problem-identifying
1,427
Comparative
1,349
Cautionary
1,191
Breakthrough
1,024
Critical
228

Contribution mix

Empirical
8,074
Methods-led
1,957
Reviews
1,804
Position pieces
636
Theoretical
36

Tone counts: 10,560 positive · 1,376 neutral · 571 negative.

Common problems researchers identify
1,655 papers · 13.2% of this field
  • Diabetes mellitus902 papers
  • Continuous glucose monitoring900 papers
  • Glycemic349 papers
  • Type 1 diabetes286 papers
  • Hypoglycemia266 papers
  • Type 2 diabetes229 papers
  • Insulin210 papers
  • Intensive care medicine184 papers

Landmark: Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range

Cautions
1,191 papers · 9.5% of this field
  • Continuous glucose monitoring703 papers
  • Diabetes mellitus576 papers
  • Glycemic378 papers
  • Hypoglycemia258 papers
  • Type 1 diabetes227 papers
  • Type 2 diabetes169 papers
  • Insulin149 papers
  • Blood Glucose Self-Monitoring136 papers

Landmark: The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial

Opportunities
5,231 papers · 41.8% of this field
  • Continuous glucose monitoring2,904 papers
  • Diabetes mellitus2,323 papers
  • Glycemic1,420 papers
  • Hypoglycemia945 papers
  • Type 1 diabetes866 papers
  • Insulin731 papers
  • Type 2 diabetes727 papers
  • Blood Glucose Self-Monitoring387 papers

Landmark: Wearable/disposable sweat-based glucose monitoring device with multistage transdermal drug delivery module

Leading institutions

Close Concerns
6,414
Breakthrough T1D
6,378
Amsterdam UMC Location University of Amsterdam
5,869
Jaeb Center for Health Research
5,339
University of Padua
4,976
Medtronic
4,824

Leading researchers

Richard M. Bergenstal
8,530
Tadej Battelino
7,220
Roy W. Beck
6,769
Thomas Danne
6,068
Stephanie A. Amiel
3,738
Revital Nimri
3,150
Andrea Facchinetti
2,944
Kelly L. Close
2,794

Highly cited breakthrough-labelled papers

  • Wearable/disposable sweat-based glucose monitoring device with multistage transdermal drug delivery module1,091 citations
  • Wearable Contact Lens Biosensors for Continuous Glucose Monitoring Using Smartphones358 citations
  • Long-term in vivo glucose monitoring using fluorescent hydrogel fibers307 citations
  • MD-Logic Artificial Pancreas System262 citations
  • Microneedle-Based Detection of Ketone Bodies along with Glucose and Lactate: Toward Real-Time Continuous Interstitial Fluid Monitoring of Diabetic Ket261 citations

Common problems researchers identify

1,536 papers · 7 recurring themes
7 cards

Swipe or scroll horizontally to browse.

Challenges in Continuous Glucose MonitoringCommon problems researchers identify · 01

Challenges in Continuous Glucose Monitoring

399 papers

26.0% of this theme group

Researchers discuss limitations and unresolved issues of continuous glucose monitoring for diabetes management.

Continuous glucose monitoring (350) · Diabetes mellitus (296) · Type 1 diabetes (128) · Type 2 diabetes (82)

Use of Continuous Glucose Monitors to Manage Type 1 Diabetes Mellitus: Progress, Challenges, and Recommendations

Continuous glucose monitoring for patients with diabetes: an evidence-based analysis.

View research history
YearShare index
2022926.4
2023926.3
2024937.2
20251005.4
Barriers to Clinical Adoption of CGMCommon problems researchers identify · 02

Barriers to Clinical Adoption of CGM

319 papers

20.8% of this theme group

Papers highlight practical and technical obstacles preventing widespread clinical use of continuous glucose sensors.

Continuous glucose monitoring (292) · Continuous monitoring (28) · Intensive care medicine (73) · Blood Glucose Self-Monitoring (54)

Continuous Glucose Monitoring: Evidence and Consensus Statement for Clinical Use

Continuous Glucose Sensing: Future Technology Developments

View research history
YearShare index
20222783.6
20232790.8
20243363.3
20252483.0
Glycemic Control Difficulties in DiabetesCommon problems researchers identify · 03

Glycemic Control Difficulties in Diabetes

300 papers

19.5% of this theme group

Studies examine factors that impede optimal blood‑glucose regulation for people with type 1 and type 2 diabetes.

Diabetes mellitus (249) · Type 2 diabetes (97) · Type 1 diabetes (108) · Glycemic (105)

Beliefs Around Hypoglycemia and Their Impacts on Hypoglycemia Outcomes in Individuals with Type 1 Diabetes and High Risks for Hypoglycemia D

Educational Impact on Glycemic Outcomes Among Children and Adolescents Diagnosed with Type 1 Diabetes

View research history
YearShare index
20221009.0
20231005.3
20241011.2
20251134.3
Issues with Self‑Monitoring of Blood GlucoseCommon problems researchers identify · 04

Issues with Self‑Monitoring of Blood Glucose

179 papers

11.7% of this theme group

Works identify user‑related and accuracy problems affecting self‑monitoring practices in diabetic patients.

Blood Glucose Self-Monitoring (102) · Diabetes mellitus (154) · Blood glucose monitoring (51) · Self-monitoring (25)

Understanding Self-Monitoring of Blood Glucose Among Individuals With Type 1 and Type 2 Diabetes

Assessing glycaemic control with self-monitoring of blood glucose

View research history
YearShare index
202213.3
202314.0
202412.8
202518.4
Insulin Pump and Artificial Pancreas LimitationsCommon problems researchers identify · 05

Insulin Pump and Artificial Pancreas Limitations

135 papers

8.8% of this theme group

Research points out technical and safety concerns surrounding insulin delivery devices and closed‑loop systems.

Insulin pump (49) · Insulin (65) · Artificial pancreas (30) · Insulin delivery (27)

Advanced Technology in the Management of Diabetes: Which Comes First—Continuous Glucose Monitor or Insulin Pump?

Continuous glucose monitoring systems in the service of artificial pancreas

View research history
YearShare index
2022521.8
2023511.9
2024414.8
2025406.9
CGM Use in Critical Care SettingsCommon problems researchers identify · 06

CGM Use in Critical Care Settings

114 papers

7.4% of this theme group

Authors report challenges of applying continuous glucose monitoring to critically ill patients in intensive care.

Critically ill (47) · Intensive care unit (22) · Intensive care medicine (51) · Hypoglycemia (52)

Inpatient Continuous Glucose Monitoring and Glycemic Outcomes

Clinical Experience with Continuous Glucose Monitoring in Adults

View research history
YearShare index
20222867.9
20232861.9
20243425.0
20252602.6
Non‑Diabetes Clinical ContextsCommon problems researchers identify · 07

Non‑Diabetes Clinical Contexts

90 papers

5.9% of this theme group

A small set of papers address unrelated medical topics that appear in the wearable literature.

MEDLINE (48) · Congenital disease (11) · Cardiothoracic surgery (7) · Poison control (5)

Arthroskopisch assistierte Korrekturosteotomie intraartikulärer operativ versorgter distaler Radiusfrakturen

Patientperspektiv ved skift i injektionsbehandling i reumatologiske ambulatorier

View research history
YearShare index
2022525.7
2023522.8
2024489.2
2025679.7

Cautions

1,127 papers · 7 recurring themes
7 cards

Swipe or scroll horizontally to browse.

Cautionary Findings for Diabetes CGMCautions · 01

Cautionary Findings for Diabetes CGM

295 papers

26.2% of this theme group

Studies advise careful interpretation of CGM data and its impact on diabetes treatment decisions.

Continuous glucose monitoring (249) · Diabetes mellitus (228) · Type 1 diabetes (117) · Type 2 diabetes (91)

The Use of Continuous Glucose Monitoring in Patients with Type 2 Diabetes

Continuous Glucose Monitoring Frequency and Glycemic Control in People With Type 2 Diabetes

View research history
YearShare index
2022926.4
2023926.3
2024937.2
20251005.4
Safety Concerns in ICU CGMCautions · 02

Safety Concerns in ICU CGM

254 papers

22.5% of this theme group

Research warns about accuracy and potential risks of continuous glucose monitoring in critically ill patients.

Continuous glucose monitoring (237) · Intensive care medicine (53) · Hypoglycemia (60) · Critically ill (22)

The Clinical Benefits and Accuracy of Continuous Glucose Monitoring Systems in Critically Ill Patients—A Systematic Scoping Review

Evaluation of the Performance of a Novel System for Continuous Glucose Monitoring

View research history
YearShare index
20222898.9
20232896.0
20243454.0
20252631.1
Insulin Therapy and CGM InteractionsCautions · 03

Insulin Therapy and CGM Interactions

174 papers

15.4% of this theme group

Papers caution about complexities when combining insulin pump therapy with continuous glucose monitoring.

Diabetes mellitus (132) · Type 1 diabetes (87) · Glycemic (70) · Insulin (37)

Associations Between Improved Glucose Control and Patient-Reported Outcomes After Initiation of Insulin Pump Therapy in Patients with Type 2

Type 1 Diabetes: Management Strategies.

View research history
YearShare index
2022774.8
2023770.8
2024669.7
2025757.2
Limitations of Blood Glucose MetersCautions · 04

Limitations of Blood Glucose Meters

114 papers

10.1% of this theme group

Analyses highlight performance gaps and user errors in traditional glucose meter technologies.

Blood Glucose Self-Monitoring (65) · Diabetes mellitus (78) · Blood glucose monitoring (27) · Glucose meter (17)

Analytical and Clinical Performance of Blood Glucose Monitors

Assessment of Self-monitoring of Blood Glucose in Individuals With Type 2 Diabetes Not Using Insulin

View research history
YearShare index
202212.2
202313.1
202412.9
202517.8
Exercise Effects on CGM AccuracyCautions · 05

Exercise Effects on CGM Accuracy

105 papers

9.3% of this theme group

Works note how physical activity can alter sensor readings and affect glycemic assessments.

Glycemic (50) · Crossover study (14) · Postprandial (17) · Physical activity (9)

Exercise lowers postprandial glucose but not fasting glucose in type 2 diabetes: a meta‐analysis of studies using continuous glucose monitor

Impact of physical exercise on sensor performance of the FreeStyle Libre intermittently viewed continuous glucose monitoring system in peopl

View research history
YearShare index
2022254.0
2023249.5
2024218.1
2025312.3
Glycemic Management Risks in ICUCautions · 06

Glycemic Management Risks in ICU

95 papers

8.4% of this theme group

Studies discuss potential adverse outcomes when targeting strict glucose control in intensive care environments.

Glycemic (43) · Hypoglycemia (35) · Intensive care (11) · Insulin (28)

Glycemic Control in the ICU

Effect of Adding Insulin Glargine on Glycemic Control in Critically Ill Patients Admitted to Intensive Care Units: A Prospective Randomized

View research history
YearShare index
2022439.8
2023427.0
2024348.5
2025431.5
Pediatric CGM Use ConsiderationsCautions · 07

Pediatric CGM Use Considerations

90 papers

8.0% of this theme group

Research emphasizes specific challenges and trade‑offs of continuous glucose monitoring in young children.

Continuous glucose monitoring (75) · Diabetes mellitus (56) · Glycemic (31) · Type 1 diabetes (26)

Systematic review and meta-analysis of the effectiveness of continuous glucose monitoring (CGM) on glucose control in diabetes

Benefits and Drawbacks of Continuous Glucose Monitoring (CGM) Use in Young Children With Type 1 Diabetes: A Qualitative Study From a Country

View research history
YearShare index
2022364.4
2023369.7
2024343.4
2025442.1

Opportunities

4,862 papers · 7 recurring themes
7 cards

Swipe or scroll horizontally to browse.

Expanding CGM for Diabetes CareOpportunities · 01

Expanding CGM for Diabetes Care

1,076 papers

22.1% of this theme group

Extensive literature explores how continuous glucose monitoring can improve outcomes across diabetes types.

Continuous glucose monitoring (958) · Diabetes mellitus (835) · Type 2 diabetes (382) · Type 1 diabetes (395)

Clinical Use of Continuous Glucose Monitoring in Adults with Type 2 Diabetes

Continuous Glucose Monitoring with Multiple Daily Insulin Treatment: Outcome Studies

View research history
YearShare index
2022926.4
2023926.3
2024937.2
20251005.4
CGM Applications in Hospital MedicineOpportunities · 02

CGM Applications in Hospital Medicine

964 papers

19.8% of this theme group

Papers identify promising roles for continuous glucose monitoring in internal and intensive care medicine.

Continuous glucose monitoring (853) · Intensive care medicine (135) · Glycemic (256) · Internal medicine (154)

Advances in Continuous Glucose Monitoring: Clinical Applications

[Continuous glucose monitoring. Utility and indications].

View research history
YearShare index
20226706.0
20236651.6
20246482.7
20254660.4
Predictive Tools for Hypoglycemia RiskOpportunities · 03

Predictive Tools for Hypoglycemia Risk

856 papers

17.6% of this theme group

Research develops models to forecast low‑glucose events and personalize diabetes management.

Diabetes mellitus (518) · Glycemic (339) · Type 1 diabetes (204) · Hypoglycemia (195)

Computing the Risk of Postprandial Hypo- and Hyperglycemia in Type 1 Diabetes Mellitus considering Intrapatient Variability and other Source

Development and validation of a hypoglycemia risk prediction tool for hospitalized patients with type 2 diabetes mellitus treated with insul

View research history
YearShare index
2022411.4
2023417.0
2024380.7
2025484.7
Non‑Invasive Wearable Glucose SensorsOpportunities · 04

Non‑Invasive Wearable Glucose Sensors

559 papers

11.5% of this theme group

Studies showcase emerging biosensor technologies aiming to measure glucose without skin penetration.

Biosensor (135) · Wearable computer (124) · Biomedical engineering (110) · Nanotechnology (64)

Noninvasive Glucose Monitoring: Increasing Accuracy by Combination of Multi-Technology and Multi-Sensors

Non-invasive wearable electrochemical sensors for continuous glucose monitoring

View research history
YearShare index
202231.5
202332.3
202432.3
202531.7
Structured Self‑Monitoring BenefitsOpportunities · 05

Structured Self‑Monitoring Benefits

521 papers

10.7% of this theme group

Evidence suggests systematic self‑monitoring can enhance glycemic control and quality of life.

Diabetes mellitus (415) · Blood Glucose Self-Monitoring (173) · Glycemic (187) · Continuous glucose monitoring (233)

Systematic Review of Self-Monitoring of Blood Glucose in Patients With Type 2 Diabetes

Contribution of Structured Self-Monitoring of Blood Glucose to the Glycemic Control and the Quality of Life in Both Insulin- and Noninsulin-

View research history
YearShare index
2022186.3
2023190.6
2024162.5
2025251.3
Advanced Insulin Delivery SystemsOpportunities · 06

Advanced Insulin Delivery Systems

498 papers

10.2% of this theme group

Research highlights next‑generation pump and closed‑loop solutions for tighter diabetes regulation.

Insulin pump (192) · Insulin (265) · Insulin delivery (126) · Type 1 diabetes (249)

Use of Continuous Glucose Monitoring in Pump Therapy Sensor Augmented Pump or Automated Insulin Delivery in Different Age Groups (0.5 to <

Safety and Efficacy of Sustained Automated Insulin Delivery Compared to Sensor and Pump Therapy in Adults with Type 1 Diabetes at High Risk

View research history
YearShare index
2022521.4
2023510.7
2024414.0
2025407.6
Machine‑Learning Enhancements for CGMOpportunities · 07

Machine‑Learning Enhancements for CGM

388 papers

8.0% of this theme group

Works demonstrate how predictive algorithms can improve glucose forecasting and risk assessment.

Continuous glucose monitoring (239) · Mean squared error (29) · Predictive modelling (21) · Diabetes mellitus (153)

Improving blood glucose level predictability using machine learning

Development and Validation of a Machine Learning Model to Predict Weekly Risk of Hypoglycemia in Patients with Type 1 Diabetes Based on Cont

View research history
YearShare index
20229.5
20238.9
20249.0
202517.6

How this field compares with the research baseline

Orientation shares compared with 25,000 papers in the reference sample.

Research orientationThis fieldReference sample
Promising33.6%37.2%
Descriptive24.6%17.7%
Problem-identifying11.4%9.6%
Comparative10.8%3.9%
Cautionary9.5%4.3%
Breakthrough8.2%26.5%
Critical1.8%0.9%

Concerns receiving less research attention

Counts and shares refer to the stated research pool. A low count describes how much of that research is recorded here, not the absence of a real-world concern.

Concern / example paperPapersShareRaised as a problemWorldwide share
Privacy & surveillanceDIY artificial pancreas systems: here to stay?410.36%15 (36.6%)0.36%
Safety & misuseDual Misuse of Insulin in an Adolescent With Type 1 Diabetes: A Case Report and Management Implications20.02%1 (50.0%)0.02%
Bias & fairnessDiscrimination and Precision of Continuous Glucose Monitoring in Staging Children With Presymptomatic Type 1 Diabetes20.02%2 (100.0%)0.02%
Concentration of compute powerEffects of Monopolar Radiofrequency Treatment on Continuous Glucose Monitoring Devices: A Small Scale Pilot Study10.01%0 (0.0%)0.01%
Energy & datacenter footprint00.0%0 (%)0.0%
Water use00.0%0 (%)0.0%
Carbon & emissions of compute00.0%0 (%)0.0%
Hardware, e-waste & supply chain00.0%0 (%)0.0%
Labour & data work00.0%0 (%)0.0%

Institution and researcher rankings use citations to their covered work. Research scope: worldwide. This may be broader than the company geography.

DEMAND, SUPPLY & PLACE

Where demand signals run ahead of mapped supply — the United Kingdom

Compare demand signals in the United Kingdom’s newsflow with the wearables categories mapped to each signal.

Expand panel +
HOW TO READ THE GAP

Signal percentile − supply percentile = gap in percentile points. Positive gaps highlight questions to investigate. A high signal can reflect spending pressure or access friction, as well as potential demand.

The comparison is relative to the signal families on this page. A supply percentile of zero means the lowest relative reading, not zero companies. It is a prioritisation clue, not measured market size or unmet demand.

COMPARISON PERIOD2025-07-01 to 2026-07-01Against 2024-07-01 to 2025-07-01Explore the signals ↓

The opportunity, in one view

Signal and mapped-supply percentiles, their gap, and change in the signal’s article share.

Swipe horizontally to compare all columns →

8 the United Kingdom demand signals compared with mapped wearables supply
Signal familySignal percentileSupply percentileRelative gapGap (points)Signal share vs prior year
Air pollution ↗Environmental Driver14.30.0+14.3+6.7%
Cancer burden ↗Disease Burden42.933.3+9.6-9.3%
Ageing & elder care ↗Disease Burden28.666.7-38.1+4.8%
Diabetes, hypertension & cardiac burden ↗Disease Burden42.9100.0-57.1+30.8%
Mental health ↗Disease Burden78.6No matching category+41.2%
Infectious outbreaks ↗Disease Burden28.6No matching category+13.7%
Maternal & child health ↗Disease Burden71.4No matching category+33.0%
Layoffs & income shocks ↗Spending Pressure92.9No matching category+37.0%

Showing all 8 signals. Select a family for its history and mapped categories.

Where the signals are loudest

All 12 city readings for these demand families in the comparison geography. the United Kingdom is highlighted.

Mentions per 10,000 articles

Each city’s reading is a share of its own coverage.

Kent382.4

Maternal & child health · Infectious outbreaks · Cancer burden

Somerset265.0

Maternal & child health · Mental health · Cancer burden

Lancashire238.2

Maternal & child health · Layoffs & income shocks · Cancer burden

North Carolina177.9

Cancer burden · Maternal & child health · Layoffs & income shocks

Birmingham170.5

Mental health · Layoffs & income shocks · Ageing & elder care

North Yorkshire159.3

Maternal & child health · Cancer burden · Layoffs & income shocks

Bristol144.5

Cancer burden · Layoffs & income shocks · Maternal & child health

Northern Ireland127.3

Cancer burden · Layoffs & income shocks · Mental health

Cornwall124.0

Cancer burden · Ageing & elder care · Diabetes, hypertension & cardiac burden

Surrey118.8

Air pollution · Mental health · Maternal & child health

Colorado116.3

Layoffs & income shocks · Mental health · Maternal & child health

Leeds111.6

Maternal & child health · Layoffs & income shocks · Diabetes, hypertension & cardiac burden

Inside the leading signals

Open any signal for its quarterly history
ENVIRONMENTAL DRIVERAir pollution+14.3percentile-point gap
THE OPERATING HYPOTHESIS

Sustained air-quality stress can pull respiratory and cardiac care demand with it.

5.8mentions per 10,000 articles+6.7%share change vs prior year

Mapped wearables categories

  • Chronic Disease Management81

Companies can appear in multiple categories; these counts are not a unique-company total.

Quarterly share of the United Kingdom coverage

Mentions per 10,000 articles · zero baseline

024792024Q3: 52024Q32024Q4: 52024Q42025Q1: 42025Q12025Q2: 62025Q22025Q3: 72025Q32025Q4: 42025Q42026Q1: 42026Q12026Q2: 52026Q2
View quarterly signal counts
Air pollution in the United Kingdom coverage
QuarterMentionsPer 10,000 articles
2024Q31175.28
2024Q41155.31
2025Q11194.71
2025Q21346.63
2025Q31887.77
2025Q4824.72
2026Q1874.39
2026Q2515.69

Where this signal concentrates in the comparison geography

DISEASE BURDENCancer burden+9.6percentile-point gap
THE OPERATING HYPOTHESIS

Cancer burden can pull screening, diagnostics and oncology capacity demand.

17.01mentions per 10,000 articles-9.3%share change vs prior year

Mapped wearables categories

  • Life Sciences102

Companies can appear in multiple categories; these counts are not a unique-company total.

Quarterly share of the United Kingdom coverage

Mentions per 10,000 articles · zero baseline

061218242024Q3: 142024Q32024Q4: 182024Q42025Q1: 212025Q12025Q2: 202025Q22025Q3: 172025Q32025Q4: 172025Q42026Q1: 152026Q12026Q2: 172026Q2
View quarterly signal counts
Cancer burden in the United Kingdom coverage
QuarterMentionsPer 10,000 articles
2024Q332114.5
2024Q440718.78
2025Q153321.08
2025Q241420.48
2025Q342017.35
2025Q430717.66
2026Q131615.93
2026Q215417.19

Where this signal concentrates in the comparison geography

North Carolina93.9 / 10,000
Bristol60.6 / 10,000
DISEASE BURDENAgeing & elder care-38.1percentile-point gap
THE OPERATING HYPOTHESIS

An ageing base can shift demand toward geriatric, home and chronic care.

8.78mentions per 10,000 articles+4.8%share change vs prior year

Mapped wearables categories

  • Chronic Disease Management81
  • Hospital At Home58

Companies can appear in multiple categories; these counts are not a unique-company total.

Quarterly share of the United Kingdom coverage

Mentions per 10,000 articles · zero baseline

03710132024Q3: 52024Q32024Q4: 102024Q42025Q1: 82025Q12025Q2: 92025Q22025Q3: 112025Q32025Q4: 52025Q42026Q1: 82026Q12026Q2: 92026Q2
View quarterly signal counts
Ageing & elder care in the United Kingdom coverage
QuarterMentionsPer 10,000 articles
2024Q31285.78
2024Q421910.11
2025Q12158.5
2025Q21869.2
2025Q327611.4
2025Q4975.58
2026Q11638.22
2026Q2829.15

Where this signal concentrates in the comparison geography

Birmingham24.7 / 10,000
DISEASE BURDENDiabetes, hypertension & cardiac burden-57.1percentile-point gap
THE OPERATING HYPOTHESIS

Chronic cardiometabolic burden can turn into decades of management demand per patient.

7.63mentions per 10,000 articles+30.8%share change vs prior year

Mapped wearables categories

  • Medical Devices104
  • Chronic Disease Management81

Companies can appear in multiple categories; these counts are not a unique-company total.

Quarterly share of the United Kingdom coverage

Mentions per 10,000 articles · zero baseline

0358102024Q3: 52024Q32024Q4: 42024Q42025Q1: 52025Q12025Q2: 82025Q22025Q3: 72025Q32025Q4: 92025Q42026Q1: 62026Q12026Q2: 62026Q2
View quarterly signal counts
Diabetes, hypertension & cardiac burden in the United Kingdom coverage
QuarterMentionsPer 10,000 articles
2024Q31125.06
2024Q41064.89
2025Q11335.26
2025Q21708.41
2025Q31827.52
2025Q41589.09
2026Q11376.91
2026Q2606.7

Where this signal concentrates in the comparison geography

DISEASE BURDENMental healthsupply not mapped
THE OPERATING HYPOTHESIS

Mental-health pressure can pull counselling and tele-psychiatry demand where it surfaces.

12.45mentions per 10,000 articles+41.2%share change vs prior year

Mapped wearables categories

This signal has no matching category in the page’s wearables market map, so no supply percentile or gap is assigned.

Quarterly share of the United Kingdom coverage

Mentions per 10,000 articles · zero baseline

04913172024Q3: 72024Q32024Q4: 102024Q42025Q1: 72025Q12025Q2: 102025Q22025Q3: 142025Q32025Q4: 112025Q42026Q1: 112026Q12026Q2: 112026Q2
View quarterly signal counts
Mental health in the United Kingdom coverage
QuarterMentionsPer 10,000 articles
2024Q31617.27
2024Q422210.25
2025Q12007.91
2025Q220410.09
2025Q336214.95
2025Q419311.1
2026Q122211.19
2026Q29911.05

Where this signal concentrates in the comparison geography

Birmingham65.1 / 10,000
Somerset54.1 / 10,000
DISEASE BURDENInfectious outbreakssupply not mapped
THE OPERATING HYPOTHESIS

Outbreak pressure can pull testing, surveillance and rapid-care demand at short notice.

6.01mentions per 10,000 articles+13.7%share change vs prior year

Mapped wearables categories

This signal has no matching category in the page’s wearables market map, so no supply percentile or gap is assigned.

Quarterly share of the United Kingdom coverage

Mentions per 10,000 articles · zero baseline

024682024Q3: 32024Q32024Q4: 62024Q42025Q1: 52025Q12025Q2: 52025Q22025Q3: 72025Q32025Q4: 52025Q42026Q1: 52026Q12026Q2: 42026Q2
View quarterly signal counts
Infectious outbreaks in the United Kingdom coverage
QuarterMentionsPer 10,000 articles
2024Q3743.34
2024Q41336.14
2025Q11455.74
2025Q21205.94
2025Q31767.27
2025Q4905.18
2026Q11145.75
2026Q2434.8

Where this signal concentrates in the comparison geography

Kent90.0 / 10,000
DISEASE BURDENMaternal & child healthsupply not mapped
THE OPERATING HYPOTHESIS

Maternal and child burden can pull immunisation, nutrition and pediatric care demand.

14.8mentions per 10,000 articles+33.0%share change vs prior year

Mapped wearables categories

This signal has no matching category in the page’s wearables market map, so no supply percentile or gap is assigned.

Quarterly share of the United Kingdom coverage

Mentions per 10,000 articles · zero baseline

061319252024Q3: 112024Q32024Q4: 132024Q42025Q1: 92025Q12025Q2: 102025Q22025Q3: 222025Q32025Q4: 92025Q42026Q1: 102026Q12026Q2: 132026Q2
View quarterly signal counts
Maternal & child health in the United Kingdom coverage
QuarterMentionsPer 10,000 articles
2024Q325411.47
2024Q428813.29
2025Q12429.57
2025Q221010.39
2025Q353322.02
2025Q41699.72
2026Q121510.84
2026Q212513.95

Where this signal concentrates in the comparison geography

Kent143.9 / 10,000
Lancashire121.6 / 10,000
Somerset108.2 / 10,000
SPENDING PRESSURELayoffs & income shockssupply not mapped
THE OPERATING HYPOTHESIS

Layoff cycles can pull discretionary spend back toward value offerings.

27.56mentions per 10,000 articles+37.0%share change vs prior year

Mapped wearables categories

This signal has no matching category in the page’s wearables market map, so no supply percentile or gap is assigned.

Quarterly share of the United Kingdom coverage

Mentions per 10,000 articles · zero baseline

091828372024Q3: 182024Q32024Q4: 172024Q42025Q1: 222025Q12025Q2: 212025Q22025Q3: 272025Q32025Q4: 232025Q42026Q1: 312026Q12026Q2: 272026Q2
View quarterly signal counts
Layoffs & income shocks in the United Kingdom coverage
QuarterMentionsPer 10,000 articles
2024Q341418.7
2024Q438517.77
2025Q157022.55
2025Q242821.18
2025Q366327.39
2025Q440023.01
2026Q163431.96
2026Q224327.12

Where this signal concentrates in the comparison geography

Colorado81.1 / 10,000
RESEARCH & CHANGING CONVERSATIONS

Related research and changing coverage

the United Kingdom wearables coverage

Expand panel +
RESEARCH CONTEXT · 2021

Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study

BMJ

1,387 citations in the snapshot

RESEARCH CONTEXT · 2022

Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study

The Lancet

1,270 citations in the snapshot

RESEARCH CONTEXT · 2022

Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study.

1,226 citations in the snapshot

RESEARCH CONTEXT · 2020

Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study

BMJ

692 citations in the snapshot

What is growing in this coverage

the United Kingdom coverage of this page's demand families

KeywordRecent articlesPrior articlesShare change
vaccine misinformation impact10523479.2%
continuing education immunization12127468.6%
vaccination-induced herd protection8622396.0%
pediatric catch-up vaccinations18962286.8%
exercise oncology674780.9%
blood pressure reduction rate413073.4%

Share changes describe coverage in the stated comparison periods, not search demand or market size.

GEOGRAPHIC FOOTPRINT

Where companies are based

Company counts, hiring and disclosed funding across the recorded hubs.

Expand panel +
8 cards

Swipe or scroll horizontally to browse.

UNDERSTAND THE LANDSCAPE

Wearables in the United Kingdom: key questions

Clear definitions for making better comparisons.

What does this landscape measure?

It measures the tracked company ecosystem, recorded funding, hiring and other available evidence. It is not a market-size estimate.

Can segment counts be added together?

No. A company can belong to several segments, so segment counts and funding can overlap.

What does a missing figure mean?

A dash or unavailable panel means the current reviewed source snapshot does not support that figure.

Company ecosystem snapshot: 4 September 2026. Funding is recorded in USD; filed accounts retain their stated currency and reporting basis. Each section identifies its own coverage. The news and research behind these sections is explorable in Prism.

Canonical landscape ↗
Coming soon